Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics
rMonitoped1
Use of Remote Photoplethysmography to Measure Heart Rate and Respiratory Rate in Pediatrics Compared to Standard Acquisition System: Prospective Comparative Trial
1 other identifier
interventional
600
1 country
1
Brief Summary
Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2023
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedStudy Start
First participant enrolled
July 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 2, 2026
January 28, 2026
January 1, 2026
1 year
December 21, 2023
January 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
measure of heart rate (HR) with remote photo-plethysmography (rPPG) at 30 seconds of recording
Assess the reliability of HR measurement using the rPPG at 30 seconds of recording versus that measured using ECG electrodes, the method taken as the gold standard, in a pediatric population
at inclusion
Secondary Outcomes (8)
HR measurement using rPPG at 60 seconds of recording
at inclusion
RR measurement using rPPG (60-second recording)
at inclusion
RR measurement using rPPG (30-second recording)
at inclusion
RR measurement using rPPG according to the age ranges ranking
at inclusion
HR measurement using rPPG according to the age ranges ranking
at inclusion
- +3 more secondary outcomes
Study Arms (1)
patents
EXPERIMENTALthe child will be placed in a dedicated, quiet, well-lit office with their parents. The following data are then collected: sex, age, phototype according to Fitzpatrick's classification. The child sits in a chair facing a camera connected to a laptop running Caducy® Medical Device software. At the same time, and following the usual procedure, three ECG electrodes will be positioned on the patient.
Interventions
Patients participating in the study will be recruited from our emergency department. The child will be placed in a dedicated, quiet, well-lit office with their parents. The following data are then collected: sex, age, phototype according to Fitzpatrick's classification. The child sits in a chair facing a camera connected to a laptop running Caducy® Medical Device software. At the same time, and following the usual procedure, three ECG electrodes will be positioned on the patient. The whole device is connected to our standard device. Once the child is immobile and ready, the Caducy® application is launched. At the same time, our standard device is activated. After 30 seconds, we will collect the HR and FR values revealed by the Caducy® application via the non-contact plethysmography method. On the other hand, it will collect the HR and FR values revealed by our standard device (Mindray® scope).
Eligibility Criteria
You may qualify if:
- Children under 18 and over 3 years of age
- Any reason for consultation or hospitalization
- Written and signed informed consent from one parent or the person with parental authority,
- Membership of a social security scheme
You may not qualify if:
- Patient with a neurocognitive disorder
- Patient in immediate vital distress,
- Known cardiac arrhythmia,
- Scleroderma
- Patients suffering from pathological tremors or muscle spasms that prevent them from remaining static for the duration of the measurement.
- Parents who do not understand and/or speak French
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondation Lenvallead
Study Sites (1)
Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL
Nice, 06200, France
Related Publications (1)
Haas-Ferrua S, Giaccardi H, Ancey B, Freyssinet E, Baranton E, Joulie A, Bendimerad I, Olla M, De Oliveira F, Moussaoui A, Boyer L, Fontas E, Tran A. Measurement of heart rate and respiratory rate using remote photoplethysmography in paediatrics: a prospective comparative trial protocol - 'rMonitoped1'. BMJ Open. 2026 Mar 19;16(3):e104840. doi: 10.1136/bmjopen-2025-104840.
PMID: 41856588DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2023
First Posted
January 30, 2024
Study Start
July 2, 2025
Primary Completion (Estimated)
July 2, 2026
Study Completion (Estimated)
July 2, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share